New techniques, technology in cataract surgery highlighted at symposium

Article

New techniques and technology in cataract surgery was the theme of a symposium Wednesday night at the World Ophthalmology Congress. The symposium touched on new phacoemulsification technology, the use of a new ophthalmic viscophthalmic device (OVD), anti-infectives, and the latest intraocular lens technology.

New techniques and technology in cataract surgery was the theme of a symposium Wednesday night at the World Ophthalmology Congress. The symposium touched on new phacoemulsification technology, the use of a new ophthalmic viscophthalmic device (OVD), anti-infectives, and the latest intraocular lens technology.

Richard Packard, MD, FACS of the United Kingdom moderated the symposium, which was sponsored by Alcon Laboratories.

Alan Crandall, MD, of the Moran Eye Institute at the University of Utah in the United States kicked off the talks by outlining why DisCoVisc has become his OVD of choice. After explaining the advantages of the newest OVD in the market, Dr. Crandall reinforced his points by presenting a video of difficult cases and how DisCoVisc assisted in performing the tough procedures.

Dr. Crandall pointed out that DisCoVisc performs well in these very difficult cases. One vial has plenty of OVD to complete a surgery. It also offers great endothelium protection, and has excellent visualization, allowing for a controlled capsulorrhexis. The OVD is easy to remove at the end of the case, which is critical.

David Allen, FRCOphth, of the United Kingdom continued the program with a thorough address on Alcon's latest phaco technology, the torsional handpiece. Dr. Allen presented the features of the handpiece, called the OZil, and explained the theoretical considerations on how it dissects a cataract.

In the wet lab, Dr. Allen pointed out that with "no flow" going through or around the needle, it was impossible to burn the cornea. He added that torsional phaco could be combined with longitudinal phaco, in a 1:4 ratio, to address the densest of cataracts.

Dr. Allen believes that torsional technology is the future of phacoemulsification. He added that the clinical impressions of smooth efficient cataract removal using the OZil is supported by the clinical studies, but additional studies are needed to make the technology conclusive.

Takayuki Akahoshi, MD, of Japan reinforced many of the points presented by Dr. Allen. He discussed micro-coaxial phaco using the OZil handpiece. Dr. Akahoshi emphasized many of the features of the handpiece, including the small sleeve within the small handpiece, the sufficient irrigation, wound protection, separate settings for both longitudinal and torsional phaco.

"Micro-coaxial phaco and implantation of 6 mm AcrySof lens should be the standard of cataract surgery, and the torsional handpiece should be very good technology to perform this surgery," said Dr. Akahoshi.

Edward Holland, MD, of the University of Cincinnati in the United States moved the discussion to anti-infective prophylaxis in cataract surgery. He presented data from the literature that supported the rates of infection during cataract surgery, most particularly endophthalmitis.

Dr. Holland also presented data on the effectiveness of the fourth-generation fluoroquinolones, and added that moxifloxacin (Vigamox) had the best effectiveness for penetration.

Dr. Holland concluded by offering a prevention list for endophthalmitis. Pre-operatively, surgeons should look for and treat blepharitis and dry eye. Intra-operatively, surgeons should administer with povidone-iodine, have careful lid draping, and protect the epithelium. If a wound leaks, put in a suture. Peri-operatively, administer the patient with a fourth-generation fluoroquinolone.

Stephen Lane, MD, of the University of Minnesota in the United States discussed the expanding role of toric and aspheric lenses. After outlining the history of monofocal technology from 1949 with the Ridley lens to today's aspheric and toric lenses, Dr. Lane explained the science behind aspheric lenses and explained the spherical aberration compensation strategy behind AcrySof IQ lens. He also looked at the studies supporting the advantages of the IQ lens.

Dr. Lane then moved onto AcrySof Toric IOL, pointing out its features, including design, stability, and cylinder power outline. He also presented the clinical data of the FDA trial involving 500 patients.

Leonardo Akaishi, MD, of Brazil concluded the presentation with his talk on the technology behind the AcrySof ReSTOR lens. Dr. Akaishi explained the features of the lens, most particularly the apodized diffractive optic. He also shared his own clinical experience with ReSTOR involving 444 patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.